Syndax IPO reboot may help the fight against cancer tumors

Syndax (SNDX) tried to go public back in June of 2014 with a different management team and less compelling story. Instead they took in capital from crossover investors, did a minor pivot and brought in a new management team to lead the company forward.

The proposed terms in 2014 were 4.3M shares at a $14 mid-point which would have resulted in a market capitalization of $171M. Syndax is back in the market now with a new underwriting team led by Morgan Stanley and Citibank. Now the proposed terms of 4.4M shares at a $15 mid . . .

Want the rest of the article?

Please login or join us as a member to view our complete content!